Insmed To Present Five Abstracts At ERS Congress 2026, Including Late-Breaking Phase 3b ENCORE Data On ARIKAYCE In Newly Diagnosed MAC Lung Disease On September 6

Benzinga Newsdesk www.benzinga.com Neutral 87.2%

Neg 0% Neu 87.2% Pos 0%

Comments

No comments yet. Be the first!